
A Comprehensive Supply Chain for Core Intermediates in Diabetes Treatment
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
In the field of pharmaceutical intermediates and APIs, Cephapirin Benzathine has become a focus of attention for many pharmaceutical companies and research institutions due to its unique pharmacological properties and broad application prospects. As a product manager with over 10 years of experience in pharmaceutical product research, I will provide you with a professional analysis of Cephapirin Benzathine and explain why choosing us as your supplier is a smart decision.
From a chemical perspective, Cephapirin Benzathine (CAS No. 97468-37-6) is the benzathine salt form of cephapirin. It belongs to the first generation of semi-synthetic broad-spectrum cephalosporin antibiotics, with the molecular formula C33H37N5O6S2.
Cephapirin Benzathine exhibits significant antibacterial activity and can effectively inhibit the growth of various bacteria, making it highly valuable in clinical applications. Research has shown that a single dose of Cephapirin Benzathine can significantly improve the reproductive performance of buffaloes suffering from subclinical endometritis, further demonstrating its effectiveness in practical applications.
In terms of storage, Cephapirin Benzathine in powder form remains stable for 3 years at -20°C, while its solutions (e.g., in DMSO) should be stored at -80°C for up to 1 year. It has a solubility of 81 mg/mL (74.49 mM) in DMSO, which makes it convenient for researchers to prepare solutions and conduct experiments.
To answer this question, it is essential to examine the structure of Cephapirin Benzathine. As a first-generation cephalosporin compound, Cephapirin Benzathine belongs to the **β-lactam antibiotic** family. Its mechanism of action primarily involves inhibiting key enzymes, such as **penicillin-binding proteins (PBPs)**, in the bacterial cell wall synthesis process. By interfering with this process, Cephapirin Benzathine disrupts the formation of the bacterial cell wall, ultimately leading to bacterial lysis and death.
The specific mechanism of action can be summarized in three aspects:
Cephapirin Benzathine binds to PBPs on the bacterial cell wall, thereby reducing their activity. PBPs are essential enzymes in bacterial cell wall synthesis, responsible for catalyzing the cross-linking and elongation of peptidoglycan chains. When PBPs are inhibited, bacterial cell wall synthesis is severely impaired.
With reduced PBP activity, bacterial cell wall formation is disrupted, leaving the cell wall fragile and unstable. Under the osmotic pressure inside the bacterial cell, the weakened wall eventually ruptures, leading to bacterial lysis and death.
Cephapirin Benzathine demonstrates significant inhibitory effects on various Gram-positive and Gram-negative bacteria. This is attributed to its unique chemical structure and mechanism of action, enabling it to target a wide range of bacterial types and exhibit broad-spectrum antibacterial properties.
Although Cephapirin Benzathine is mainly used in the pharmaceutical field, its wide application prospects and unique pharmacological properties make it an intriguing compound.
– **Animal Studies**
Researchers have adjusted the dosage and formulation of Cephapirin Benzathine in animal experiments to explore its pharmacological effects and pharmacokinetics in different animals. Such studies not only contribute to the development of new drugs but also provide strong support for veterinary clinical practices. In this sense, Cephapirin Benzathine can be considered a safeguard for livestock health.
– **Research Tool**
Cephapirin Benzathine can also serve as a research tool for studying antibiotic mechanisms, bacterial resistance, and other important scientific questions. These studies not only deepen our understanding of antibiotics but also provide a scientific basis for developing more rational treatment protocols.
As a manufacturer specializing in pharmaceutical intermediates and APIs, **Tianming** has 14 years of industry experience. We offer the following advantages to provide you with high-quality Cephapirin Benzathine products:
We adhere to GMP standards and ISO management systems to ensure that our products meet international pharmacopeia standards. Our R&D team and testing center are equipped with advanced instruments for comprehensive quality testing and monitoring.
With years of experience in pharmaceutical intermediates and API production, we have accumulated rich expertise in production technology and processes. Our production lines use advanced automated equipment and intelligent management systems to ensure the stability and consistency of product quality.
Tianming has a dedicated customer service team to provide you with comprehensive product consultation and technical support. Whether you are a researcher or a pharmaceutical company, we can offer customized products and service solutions tailored to your needs.
We are committed to providing high-quality products and services at favorable prices. Our pricing is reasonable and transparent, helping you save costs and improve procurement efficiency.
Cephapirin Benzathine, with its broad application prospects, unique pharmacological properties, and significant antibacterial activity, has become a top choice for many pharmaceutical companies and research institutions. If you are in need of Cephapirin Benzathine, choosing us as your supplier will provide you with high-quality products, professional customer service, and competitive pricing.
We look forward to working with you to drive innovation and development in the pharmaceutical industry!

End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.

Drawing from on-the-ground experience in China’s top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when to buy from the workhorses of mature production.

This case study, based on publicly available academic literature and patents, focuses on the application of synthetic route optimization in improving the yield and purity of Active Pharmaceutical Ingredients (APIs).
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.